| Cancer Stem Cell News 8.42 October 30, 2019 | |
 |
|
|
|
TOP STORYTAF1 Plays a Critical Role in AML1-ETO Driven Leukemogenesis Investigators demonstrated that TATA-Box binding protein associated factor 1 (TAF1) associated with K43 acetylated acute myeloid leukemia l (AML1)-ETO and this association played a pivotal role in the proliferation of AML1-ETO-expressing AML cells. [Nat Commun] Full Article |
|
|
|
|
|
|
|
PUBLICATIONS(Ranked by impact factor of the journal)Scientists demonstrated that miR24-2 promoted the proliferation ability in vitro and the tumorigenic ability in vivo in human liver cancer stem cells. Mechanically, the miR24-2 targeted for 3′-UTR of protein arginine methyltransferase 7 inhibited the translational ability of prmt7 gene. [Mol Ther] Abstract Mitochondrial Damage Mediated by miR-1 Overexpression in Cancer Stem Cell The authors indicated that the overexpression of an microRNA (miR-1) could destroy the mitochondria of cancer stem cells. MiR-1 was downregulated in melanoma and breast cancer stem cells compared with cancer non-stem cells. However, the upregulation of miR-1 in cancer non-stem cells did not induce mitochondrial damage. [Mol Ther] Full Article A Novel BMI-1 Inhibitor QW24 for the Treatment of Stem-Like Colorectal Cancer Colorectal cancer stem-like cell lines HCT116 and HT29 were used for screening more than 500 synthetic compounds by sulforhodamine B (SRB) cell proliferation assay. The candidate compound was studied in vitro by SRB cell proliferation assay, western blotting, cell colony formation assay, quantitative real-time PCR, flow cytometry analysis, and transwell migration assay. [J Exp Clin Cancer Res] Full Article Scientists postulated that cellular stress such as ionizing radiation could enhance the transdifferentiation of glioblastoma stem-like cells into tumor derived endothelial cells. Glioblastoma stem-like cell neurospheres isolated from three different patients were irradiated or not and were then transdifferentiated into tumor derived endothelial cells. [Cell Death Dis] Full Article Iguratimod encapsulated in poly(lactic-co-glycolic acid) nanoparticles with an average size of 100-200 nm was prepared using modified double-emulsion method. Cell counting kit-8 analysis of glioma cancer cells and glioma stem-like cells demonstrated significant inhibition of their growth treated with iguratimod encapsulated-poly (lacti-co-glycolic acid) nanoparticles. [Nanomedicine] Abstract | Graphical Abstract Researchers proposed a novel mechanism that regulated the maturation process of nogo receptor through an interaction with vimentin. The inhibition of TGFβ1 activity by LY2109761 attenuated the migration/invasion of glioblastoma multiforme cells by upregulating cell-surface nogo receptor. [Exp Mol Med] Full Article LXRβ Controls Glioblastoma Cell Growth, Lipid Balance, and Immune Modulation Independently of ABCA1 Investigators showed that high cell density induced ABCA1 expression in glioblastoma cells, enabling them to get rid of excess cholesterol generated by an activated cholesterol biosynthesis pathway. [Sci Rep] Full Article Development of an Anti-CD45RA-Quantum Dots Conjugated scFv to Detect Leukemic Cancer Stem Cells Following insertion of scFv gene into a pET32a-lic vector and expression in Escherichia coli and purification, the purified scFv was conjugated with carbon dots and used for the detection of CD45RA+ cells while CD45RA– cells served as negative control. [Mol Biol Rep] Abstract The expression of ALDH1A3 in the glioma cell line U87 was detected by quantitative real-time PCR and RNA-Seq technology was applied to investigate differentially expressed genes before and after silencing the ALDH1A3 gene. [Cell Biol Int] Abstract Subscribe to one of our other 19 science newsletters such as Neural Cell News & Hematopoiesis News. |
|
|
|
|
|
|
|
REVIEWSInsights in the Immunobiology of Glioblastoma Tumor heterogeneity that often leads to distinct functional phenotypes contributes to glioblastoma indispensable growth and aggressiveness. The complex interaction of neoplastic cells with tumor microenvironment along with the presence of cancer stem-like cells largely confers to extrinsic and intrinsic glioblastoma heterogeneity. [J Mol Med (Berl)] Abstract Visit our reviews page to see a complete list of reviews in the cancer stem cell research field. |
|
|
|
|
INDUSTRY NEWSPascal Biosciences Inc. and Y-Biologics announced a research collaboration agreement for the discovery and development of novel bispecific antibodies for the treatment of leukemia. Under the terms of the agreement, Y-Biologics will contribute its novel bispecific antibody platform technology, ALiCE, and Pascal will utilize its proprietary antibodies. [Pascal Biosciences Inc. (GlobeNewswire, Inc.)] Press Release Molecular Targeting Technologies, Inc. announced that the NIBIB has granted Molecular Targeting Technologies, Inc. an exclusive worldwide license to commercialize patented technology invented by Drs. Xiaoyuan Chen and Orit Jacobson. [Molecular Targeting Technologies, Inc.] Press Release | |
|
|
|
POLICY NEWSAcademics in Ukraine Fighting Against Rampant Misconduct Plagiarism, pseudoscience, bribes, and cheating. The threats to academia in Ukraine are many, according to false-science, a group of around 10 Ukrainian scientists dedicated to battling cheaters. [The Scientist] Editorial White House to Host Closed-Door Summit on US Research Enterprise The White House Office of Science and Technology Policy will host a one-day meeting in Washington, DC, to discuss a host of hot-button issues affecting the US research community. [ScienceInsider] Editorial Beware the UK Government’s Brexit Promises There’s a research group in Britain that has become a staple of the country’s news shows, and it’s called The UK in a Changing Europe. On most nights, the team of political scientists, economists and lawyers dispassionately responds to broadcasters’ questions on the impact — economic, political and societal — of the United Kingdom’s departure from the European Union. [Nature News] Editorial
|
|
EVENTSNEW Gene Regulation: From Mechanisms to Disease Visit our events page to see a complete list of events in the community.
|
|
JOB OPPORTUNITIESNEW Postdoctoral Position – Immune-targeting of Leukemic Stem Cells (Karolinska Institutet) Postdoctoral Studentship – HOX Interactors for Leukemia (University of Manchester) Faculty Positions – Molecular and Cellular Biology (Baylor College of Medicine) Postdoctoral Scholar – Cancer Biology (University of Kentucky) Postdoctoral Position – Cellular Immunotherapy for Cancer (Tactiva Therapeutics) Postdoctoral Position – Cancer Biology (Weill Cornell Medicine) Assistant, Associate, or Professor – Hematology (Stanford University) Assistant, Associate or Professor – Oncological Sciences (University of Utah) Associate Professor – T-Cell Therapy (Dana-Farber Cancer Institute) Postdoctoral Researcher – Cancer Stem Cells in Glioblastoma (The Institut Curie Research Center) Postdoctoral Associate – Hematopoietic Stem Cells and Leukemia (The Jackson Laboratory)
Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
|
|
|
Have we missed an important article or publication in Cancer Stem Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. |
|
|
